![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Sinopep-allsino Biopharmaceutical Co., Ltd. Lianyungang Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Octreotide, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-302 - Rev 00
This Chemical Type CEP, issued on June 21, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2414 associated with this CEP further emphasizes